×
About 4,268 results

ALLMedicine™ Crohn Disease Center

Research & Reviews  1,420 results

Short-Bowel Syndrome
http://emedicine.medscape.com/article/193391-overview

Mar 16th, 2023 - Practice Essentials Each year in the United States, many patients undergo resection of long segments of small intestine for various disorders, including inflammatory bowel disease (IBD), malignancy, mesenteric ischemia, and others. Juvenile surviv...

Short-Bowel Syndrome
https://emedicine.medscape.com/article/193391-overview

Mar 16th, 2023 - Practice Essentials Each year in the United States, many patients undergo resection of long segments of small intestine for various disorders, including inflammatory bowel disease (IBD), malignancy, mesenteric ischemia, and others. Juvenile surviv...

Short-Bowel Syndrome
https://emedicine.medscape.com/article/193391-print

Mar 16th, 2023 - Practice Essentials Each year in the United States, many patients undergo resection of long segments of small intestine for various disorders, including inflammatory bowel disease (IBD), malignancy, mesenteric ischemia, and others. Juvenile surviv...

Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence.
https://doi.org/10.1111/imj.16072
Internal Medicine Journal; Seleq S, Weilert F et. al.

Mar 15th, 2023 - Inflammatory bowel disease (IBD) prevalence is rising globally; however, indigenous groups are underrepresented. Waikato, New Zealand, is a large region with a high proportion of Māori patients. In Canterbury in 2006, 1% of patients with IBD were ...

Autoimmune Skin Conditions: Psoriasis.
https://www.ncbi.nlm.nih.gov/pubmed/36913657
FP Essentials; Clebak KT, Helm LA et. al.

Mar 14th, 2023 - Psoriasis is a chronic, inflammatory skin condition with significant effect on quality of life. It affects 3.2% of the United States population. Psoriasis is caused by an interaction between genetic and environmental triggers. Associated condition...

see more →

Guidelines  4 results

ACR Appropriateness Criteria® Crohn Disease-Child.
https://doi.org/10.1016/j.jacr.2022.02.020
Journal of the American College of Radiology : JACR; , Moore MM et. al.

May 14th, 2022 - Crohn disease is an inflammatory condition of the gastrointestinal tract with episodes of exacerbation and remission occurring in children, adolescents, and adults. Crohn disease diagnosis and treatment depend upon a combination of clinical, labor...

ACR Appropriateness Criteria® Crohn Disease.
https://doi.org/10.1016/j.jacr.2020.01.030
Journal of the American College of Radiology : JACR; , Kim DH et. al.

May 7th, 2020 - Three common clinical scenarios involving use of imaging in Crohn disease are covered. These include the initial evaluation of Crohn disease when the diagnosis has not been previously established, the evaluation for anticipated exacerbation of kno...

European Society of Paediatric Radiology abdominal imaging task force: statement on ima...
https://doi.org/10.1007/s00247-019-04375-8
Pediatric Radiology; Watson TA, Petit P et. al.

Mar 28th, 2019 - Very early onset inflammatory bowel disease (VEO-IBD) is defined as disease presenting before the age of 6. These children require a tailored imaging approach because conventional imaging studies can be difficult to perform at such a young age. Un...

Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Po...
https://doi.org/10.1097/MPG.0000000000001562
Journal of Pediatric Gastroenterology and Nutrition; Amil-Dias J, Kolacek S et. al.

Mar 8th, 2017 - The incidence of Crohn disease (CD) has been increasing and surgery needs to be contemplated in a substantial number of cases. The relevant advent of biological treatment has changed but not eliminated the need for surgery in many patients. Despit...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  66 results

Transcutaneous VNS to Treat Pediatric IBD
https://clinicaltrials.gov/ct2/show/NCT03863704

Mar 7th, 2023 - The current available therapies for inflammatory bowel disease (IBD), including immunomodulator and biologic medications may have toxicities limiting use or inadequate effect. We propose a novel approach to the treatment of IBD by using transcutan...

Role of C-Reactive Protein /Albumin Ratio in Evaluation of Disease Activity in Patients With Inflammatory Bowel Disease
https://clinicaltrials.gov/ct2/show/NCT05738915

Feb 22nd, 2023 - Inflammatory bowel disease (IBD) is defined as a life long chronic inflammatory disease affecting the gastrointestinal tract resulting from the interaction of environmental and genetic elements, has been a global healthcare problem with a steadily...

Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease
https://clinicaltrials.gov/ct2/show/NCT03983837

Feb 21st, 2023 - Chronic granulomatous disease (CGD) is a rare genetic immune disorder that results in recurrent and severe infections, and inflammatory dysregulation. For almost 50% of patients with CGD, this inflammation causes severe inflammatory bowel disease ...

Assessment of Intestinal Inflammation by Infrared Thermography in Pediatric Crohn Disease
https://clinicaltrials.gov/ct2/show/NCT05710276

Feb 6th, 2023 - The assessment of digestive inflammation and disease activity in paediatrics Crohn's disease (CD) is currently based on anamnestic, clinical and paraclinical elements such as the paediatric CD activity index (wPCDAI) , faecal calprotectin measurin...

Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
https://clinicaltrials.gov/ct2/show/NCT03278912

Jan 25th, 2023 - Over 1 million people suffer from IBD in the United States. Although the exact pathogenesis is unclear, IBD results from an inappropriate inflammatory response to intestinal microbes which is influenced by the environment in a genetically suscepti...

see more →

News  208 results

Exophytic Firm Papulonodule on the Labia in a Patient With Nonspecific Gastrointestinal Symptoms
https://www.mdedge.com/dermatology/article/260635/dermatopathology/exophytic-firm-papulonodule-labia-patient-nonspecific
Gabrielle M. Peck, BA, Joy Mosser-Goldfarb, MD

Jan 17th, 2023 - The Diagnosis: Cutaneous Crohn Disease Kinyoun and Grocott-Gomori methenamine-silver staining of the labial biopsy were negative for mycobacteria and fungi, respectively. A complete blood cell count, erythrocyte sedimentation rate, C-reactive prot.

Pyostomatitis Vegetans With Orofacial and Vulvar Granulomatosis in a Pediatric Patient
https://www.mdedge.com/dermatology/article/260302/pediatrics/pyostomatitis-vegetans-orofacial-and-vulvar-granulomatosis
Rachel Nelson, MD, Lauren Love, MD et. al.

Dec 20th, 2022 - Case Report A 7-year-old girl who was otherwise healthy was referred by pediatric gastroenterology for evaluation of cutaneous Crohn disease (CD). The patient had a 4-year history of persistent lip swelling and a 3-year history of asymmetric eryth.

Severe abdominal pain and vomiting
https://www.mdedge.com/uc-crohn-disease-challenge-center/article/258756/uc-crohn-disease/severe-abdominal-pain-and-vomiting

Oct 20th, 2022 - On the basis of the patient’s family history, personal history, and presentation, the likely diagnosis is Crohn disease. Although the disease may be diagnosed at any age, onset shows a bimodal distribution, with the first, more predominant wave oc.

Incidence and Risk Factors for Biliary Tract Cancers
https://www.onclive.com/view/incidence-and-risk-factors-for-biliary-tract-cancers

Oct 11th, 2022 - Transcript: Milind Javle, MD: Before we get there, Anjana, you mentioned that you’re seeing more patients in your clinic now, and that’s also my experience. We’re seeing a lot more biliary cancer, and I’m amazed that some fellows come to my clini...

Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect
https://www.mdedge.com/dermatology/article/258465/acne/vedolizumab-induced-acne-fulminans-uncommon-and-severe-adverse
Kaitlin Blankenship, MD, Laura Burns, MD et. al.

Oct 6th, 2022 - To the Editor: Vedolizumab is an innovative monoclonal antibody targeted against the α4β7 integrin that is approved for treatment of moderate to severe ulcerative colitis and Crohn disease refractory to standard treatment. 1 Vedolizumab is thought.

see more →

Patient Education  2 results see all →